Dalid, Moises P.

HRN: 06-35-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/02/2023
02/09/2023
IV
750mg
OD Every Other Day
Progressing Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: